This image is an infographic about respiratory syncytial virus (RSV). It highlights the impact of RSV, noting 33 million episodes of severe respiratory infection, 3.6 million pediatric hospitalizations, and 101,000 deaths, primarily affecting infants under 6 months. The infographic emphasizes available tools like maternal vaccines and monoclonal antibodies to combat RSV.

#RSV has long put infants at risk of severe respiratory disease—but with maternal vaccines and monoclonal antibodies, we have new ways to fight it.

📣 Help spread the word with our social media tools: https://bit.ly/4aTn9yF

#RSVAwareness #RSVVW26

Maternal vaccines and monoclonal antibodies are powerful new tools to protect children from respiratory syncytial virus (#RSV).

Join PATH at #RSVVW26 this week, and check out our resources to spread the word about RSV prevention: https://bit.ly/4rqGPQz

📍 Rome | 17–20 February 2026

We are pleased to join the #RSVVW26 Conference in Rome 🇮🇹, a global gathering dedicated to advancing novel preventative and therapeutic interventions against #RSV.

If you’re attending the conference in Rome, let's connect!

#ReSViNET #HealthConference #Globalhealth